Wave Life Sciences (WVE) EBITDA Margin Growth (3y) (2018 - 2026)
Wave Life Sciences (WVE) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 15,241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,241.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 163,398.00 |
| Jun 30, 2024 | 125,700.00 |
| Dec 31, 2023 | 25,685.00 |
| Sep 30, 2023 | 100,657.00 |
| Jun 30, 2023 | 117,086.00 |
| Mar 31, 2023 | 96,723.00 |
| Dec 31, 2022 | -99,377.00 |
| Sep 30, 2022 | -1.18 Mn |
| Jun 30, 2022 | -1.06 Mn |
| Mar 31, 2022 | -59,094.00 |
| Dec 31, 2021 | -69,388.00 |
| Sep 30, 2021 | 83,004.00 |
| Jun 30, 2021 | -68,513.00 |
| Dec 31, 2020 | 251,656.00 |
| Sep 30, 2020 | 100,649.00 |
| Jun 30, 2020 | 97,209.00 |
| Mar 31, 2020 | 407,451.00 |
| Dec 31, 2019 | 21,507.00 |